RESUMO
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) use may have long-term neurotoxic effects. In this study, positron emission tomography with the tracer alpha-[(11) C]methyl-l-tryptophan ((11) C-AMT) was used to compare human brain serotonin (5-HT) synthesis capacity in 17 currently drug-free MDMA polydrug users with that in 18 healthy matched controls. Gender differences and associations between regional (11) C-AMT trapping and characteristics of MDMA use were also examined. MDMA polydrug users exhibited lower normalized (11) C-AMT trapping in pre-frontal, orbitofrontal, and parietal regions, relative to controls. These differences were more widespread in males than in females. Increased normalized (11) C-AMT trapping in MDMA users was also observed, mainly in the brainstem and in frontal and temporal areas. Normalized (11) C-AMT trapping in the brainstem and pre-frontal regions correlated positively and negatively, respectively, with greater lifetime accumulated MDMA use, longer durations of MDMA use, and shorter time elapsed since the last MDMA use. Although the possibility of pre-existing 5-HT alterations pre-disposing people to use MDMA cannot be ruled out, regionally decreased 5-HT synthesis capacity in the forebrain could be interpreted as neurotoxicity of MDMA on distal (frontal) brain regions. On the other hand, increased 5-HT synthesis capacity in the raphe and adjacent areas could be due to compensatory mechanisms.
Assuntos
Encéfalo/efeitos dos fármacos , N-Metil-3,4-Metilenodioxianfetamina/efeitos adversos , Serotonina/metabolismo , Transtornos Relacionados ao Uso de Substâncias/patologia , Triptofano/análogos & derivados , Adulto , Antidepressivos de Segunda Geração/sangue , Antidepressivos de Segunda Geração/farmacologia , Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Mapeamento Encefálico , Feminino , Humanos , Masculino , Tomografia por Emissão de Pósitrons , Autorrelato , Fatores Sexuais , Transtornos Relacionados ao Uso de Substâncias/diagnóstico por imagem , Triptofano/sangue , Triptofano/farmacologia , Adulto JovemRESUMO
Increasing serotonin decreases quarrelsome behaviours and enhances agreeable behaviours in humans. Antidepressants, even those whose primary action is not on serotonin, seem to increase serotonin function. We suggest that antidepressants act in part by effects on social behaviour, which leads to a gradual improvement in mood. We review the evidence supporting the idea that antidepressants may be moving behaviour from quarrelsome to agreeable. The more positive social responses of interaction partners would initiate a cycle of more positive social behaviour, and this iterative process would result in a clinically significant improvement in mood.
Assuntos
Antidepressivos/farmacologia , Comportamento Social , Animais , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/fisiopatologia , Transtorno Depressivo/psicologia , Humanos , Modelos Psicológicos , Serotonina/metabolismoRESUMO
The acute tryptophan depletion (ATD) technique has been used extensively to study the effect of low serotonin in the human brain. This review assesses the validity of a number of published criticisms of the technique and a number of previously unpublished potential criticisms. The conclusion is that ATD can provide useful information when results are assessed in conjunction with results obtained using other techniques. The best-established conclusion is that low serotonin function after tryptophan depletion lowers mood in some people. However, this does not mean that other variables, altered after tryptophan depletion, are necessarily related to low serotonin. Each aspect of brain function has to be assessed separately. Furthermore, a negative tryptophan depletion study does not mean that low serotonin cannot influence the variable studied. This review suggests gaps in knowledge that need to be filled and guidelines for carrying out ATD studies.
Assuntos
Afeto/fisiologia , Temas Bioéticos , Alimentos Formulados/efeitos adversos , Serotonina/fisiologia , Triptofano/deficiência , Animais , Encéfalo/irrigação sanguínea , Encéfalo/metabolismo , Humanos , Serotonina/metabolismo , Triptofano/metabolismoRESUMO
Recent research indicates that suicide rates are elevated in those living at higher altitudes in both the United States and South Korea. A possible mechanism that was proposed is metabolic stress associated with hypoxia. This commentary discusses these results, and also the association between elevated suicide rates and other conditions associated with hypoxia (smoking, chronic obstructive pulmonary disease and asthma). Tryptophan hydroxylase may not normally be saturated with oxygen, so mild hypoxia would decrease serotonin synthesis. Low brain serotonin is known to be associated with suicide. Thus, the commentary proposes and discusses the hypothesis that decreased brain serotonin synthesis associated with hypoxia is a mechanism that may contribute to suicide in conditions causing hypoxia. Finally the commentary proposes various studies that could test aspects of this hypothesis.
Assuntos
Altitude , Asma/psicologia , Hipóxia/metabolismo , Doença Pulmonar Obstrutiva Crônica/psicologia , Serotonina/biossíntese , Fumar/psicologia , Suicídio/estatística & dados numéricos , Asma/complicações , Asma/metabolismo , Humanos , Hipóxia/complicações , Incidência , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/metabolismo , República da Coreia/epidemiologia , Fumar/metabolismo , Estados Unidos/epidemiologiaRESUMO
Recent clinical trials suggest that 3 single biological treatments have effects that persist. Based on research showing that the muscles involved in facial expressions can feed back to influence mood, a single trial diminishing glabella frown lines with botulinum toxin demonstrated a significant antidepressant effect for 16 weeks. Based primarily on research with animal models of depression suggesting that glutamate may be involved in depression, the N-methyl-D-aspartate antagonist ketamine has been tested in several trials. A single dose decreased depression for up to a week. The reported effects of the use of mushrooms containing psilocybin by a number of cultures around the world has stimulated several trials showing beneficial effects of a single dose of psilocybin for over a year in healthy people, and for up to 3 months in patients with anxiety disorders who have advanced cancer. This article discusses these studies, their rationale, their possible mechanisms of action, the future clinical research required to establish these therapies and the basic research required to optimize single treatments that have lasting effects.
Assuntos
Transtornos de Ansiedade/tratamento farmacológico , Transtorno Depressivo/tratamento farmacológico , Afeto/efeitos dos fármacos , Anestésicos Dissociativos/farmacologia , Animais , Ansiolíticos/farmacologia , Antidiscinéticos/farmacologia , Atitude , Comportamento/efeitos dos fármacos , Toxinas Botulínicas/farmacologia , Expressão Facial , Alucinógenos/farmacologia , Humanos , Ketamina/farmacologia , Efeito Placebo , Psilocibina/farmacologia , Resultado do TratamentoRESUMO
BACKGROUND: Despite evidence that bright light can improve mood, the neurobiology remains poorly understood. Some evidence implicates the catecholamines. In the present study, we measured the effects of transiently decreasing dopamine (DA) synthesis on mood and motivational states in healthy women with mild seasonal mood changes who were tested in either bright or dim light. METHODS: On 2 test days, participants slept overnight in a light-controlled room. On the morning of each session, half of the participants awoke to gradual increases of bright light, up to 3000 lux, and half to dim light (10 lux). For all participants, DA was reduced on 1 of the test days using the acute phenylalanine/tyrosine depletion (APTD) method; on the other day, they ingested a nutritionally balanced control mixture (BAL). Beginning 4 hours postingestion, participants completed subjective mood questionnaires, psychological tests and a progressive ratio breakpoint task during which they worked for successive units of $5. RESULTS: Thirty-two women participated in our study. The APTD lowered mood, agreeableness, energy and the willingness to work for monetary reward. The effects on energy and motivation were independent of light, while the effects on mood and agreeableness were seen in the dim condition only, being prevented by bright light. LIMITATIONS: Acute phenylalanine/tyrosine depletion might affect systems other than DA. The sample size was small. CONCLUSION: These results suggest that increased DA function may be responsible for some of the beneficial effects of light, while adding to the evidence that the neurobiology of mood and motivational states can be dissociated.
Assuntos
Afeto/fisiologia , Dopamina/fisiologia , Luz , Motivação/fisiologia , Transtorno Afetivo Sazonal/fisiopatologia , Transtorno Afetivo Sazonal/psicologia , Adulto , Afeto/efeitos dos fármacos , Dopamina/deficiência , Feminino , Humanos , Motivação/efeitos dos fármacos , Fenilalanina/sangue , Fenilalanina/farmacologia , Desempenho Psicomotor/efeitos dos fármacos , Desempenho Psicomotor/fisiologia , Recompensa , Transtorno Afetivo Sazonal/diagnóstico , Transtorno Afetivo Sazonal/metabolismo , Tirosina/sangue , Tirosina/farmacologiaRESUMO
BACKGROUND: Previous research has shown that many people experience a temporary worsening of mood following acute tryptophan depletion (ATD) and that concurrent use of serotonergic medications may influence such mood responses. We investigated mood and other consequences of ATD in women with bulimia nervosa who were or were not using concurrent serotonergic medications compared with women without bulimia. METHODS: Women self-referred for treatment of bulimia who were either not currently using psychoactive medications (n = 26) or who were using serotonin reuptake inhibitor medications exclusively (n = 13), as well as medication-free normal-eater control women (n = 25) completed interviews and questionnaires assessing eating and comorbid psychopathology and then participated in an ATD procedure involving balanced and tryptophan-depleted conditions. RESULTS: In the tryptophan-depleted condition, the groups displayed similar and significant decrements in plasma tryptophan levels and mood. Women with bulimia who were using serotonin reuptake inhibitors, but not the other groups, also reported an increased urge to binge eat in the tryptophan-depleted condition. LIMITATIONS: Application of medication in participants with bulimia was not random. CONCLUSION: Acute reductions in serotonin availability produced similar mood-reducing effects in bulimic and nonbulimic women. To the extent that ATD affected subjective experiences pertinent to eating (i.e., urge to binge eat), such effects appeared to depend upon ATD-induced competition with the therapeutic effects of serotonergic medications.
Assuntos
Afeto/fisiologia , Bulimia Nervosa/metabolismo , Comportamento Alimentar/fisiologia , Triptofano/deficiência , Adulto , Afeto/efeitos dos fármacos , Análise de Variância , Bulimia Nervosa/sangue , Bulimia Nervosa/tratamento farmacológico , Dieta , Método Duplo-Cego , Comportamento Alimentar/efeitos dos fármacos , Feminino , Humanos , Entrevistas como Assunto , Testes Psicológicos , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Inquéritos e Questionários , Fatores de Tempo , Triptofano/sangue , Adulto JovemRESUMO
Differences in the rates of affective disorders between women and men may relate to gender differences in gonadal steroid levels such as estrogen that have effects on brain monoamines important to mood regulation. Changes in estrogen secretion patterns during the perimenopause and menopause may be relevant to the increased risk for affective symptoms at that time. This study examined whether 17beta-estradiol (E2) administration can modify the mood effects of experimental psychosocial stress following acute monoamine depletion in postmenopausal women. Subjects consisted of 15 normal postmenopausal women (PMW) (ages 67.1+/-11.2 years) blindly placed on either oral placebo or E2 (1 mg/day for 1 month, then 2 mg/day for 2 months). At the end of the 3-month treatment phase, subjects participated in three blinded depletion challenges in which they ingested each of three amino-acid mixtures: deficient in tryptophan, deficient in phenylalanine/tyrosine, or nutritionally balanced. After 5 h, subjects performed the Trier Social Stress Test (TSST), followed by mood and anxiety ratings. E2-treated subjects exhibited a significant increase in negative mood and anxiety after the TSST compared to placebo-treated women. These effects were independent of monoamine depletion and were not manifest before the TSST or at baseline. Exogenous estrogen administration in PMW may alter or modulate emotional reactivity to stressful events and may alter the sensitivity of emotional regulation. This modulation appears to be independent of alterations in monoaminergic neurotransmission. The dose of estrogen used after menopause may be important in determining the effects of gonadal steroids on emotional regulation.
Assuntos
Afeto/efeitos dos fármacos , Monoaminas Biogênicas/sangue , Estradiol/administração & dosagem , Estrogênios/administração & dosagem , Pós-Menopausa/efeitos dos fármacos , Estresse Psicológico/complicações , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Método Duplo-Cego , Esquema de Medicação , Estradiol/sangue , Estrogênios/sangue , Feminino , Alimentos Formulados , Humanos , Imunoensaio , Pessoa de Meia-Idade , Testes Neuropsicológicos , Medição da Dor , Pós-Menopausa/fisiologia , Pós-Menopausa/psicologia , Escalas de Graduação PsiquiátricaRESUMO
BACKGROUND: Data concerning the effects of alcohol on social interaction in everyday life are limited. METHODS: Healthy volunteers in 4 studies of social behaviors and mood were instructed to complete record forms immediately after a social interaction had occurred, a method known as event-contingent recording. Record forms asked questions about quarrelsome, agreeable, dominant, and submissive behaviors; about aspects of mood; and, in 3 studies, about perceptions of others. Each form also contained a question about alcohol consumption prior to a social interaction. For the present report, only social interactions taking place in the evening and outside the work setting were included. Only individuals who consumed alcohol at least once in these circumstances were included (n = 171). RESULTS: Social interactions involving alcohol were primarily characterized by higher levels of agreeable behaviors, by perceptions of greater agreeableness in others, and by more positive mood. Alcohol consumption was not associated with higher levels of quarrelsomeness. CONCLUSIONS: Alcohol consumption in a social context may have predominantly positive effects, an observation which is at odds with most alcohol-induced aggression experiments performed in laboratory settings. Drinking in everyday life may be less likely to result in aggression because, unlike in most laboratory experiments, individuals can choose among a variety of behaviors in response to social cues and the alcohol dose consumed is usually lower. Event-contingent recording provides a new approach for the study of alcohol's effects in everyday life and the conditions in which alcohol might result in interpersonal aggression.
Assuntos
Consumo de Bebidas Alcoólicas/psicologia , Relações Interpessoais , Comportamento Social , Adulto , Idoso , Feminino , Amigos/psicologia , Humanos , Masculino , Pessoa de Meia-Idade , Percepção/fisiologia , Periodicidade , Meio Social , Inquéritos e QuestionáriosRESUMO
We investigated the influence of bright light exposure on the mood-lowering effect of acute tryptophan depletion (ATD). Mildly seasonal healthy young women without a personal or family history of psychiatric disorders remained in either dim or bright light during two test days. Tryptophan-deficient and nutritionally balanced amino acid mixtures were administered in counterbalanced order. Mood state was assessed using the Profile of Mood States (POMS) and Visual Analogue Scales (VAS). In dim light, ATD decreased POMS scores across most subscales, indicating a worsening of mood. In bright light, mood was unaffected by ATD. Thus, bright light blocked the worsening of mood caused by ATD. This was also observed on the positive mood VAS. These results indicate a direct, immediate interaction between bright light and serotonin function. Bright light might help protect against ATD-induced mood change by increasing serotonin above the threshold level below which there is a lowering of mood.
Assuntos
Afeto/fisiologia , Fototerapia , Transtorno Afetivo Sazonal/terapia , Triptofano/deficiência , Adolescente , Adulto , Aminoácidos/administração & dosagem , Aminoácidos/sangue , Aminoácidos/farmacologia , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Luz , Escalas de Graduação Psiquiátrica , Transtorno Afetivo Sazonal/metabolismo , Estações do Ano , Sono/efeitos dos fármacosRESUMO
OBJECTIVE: To clarify dopamine's role in alcohol self-administration in a heterogeneous sample of drinkers using acute phenylalanine/tyrosine depletion (APTD). METHODS: Sixteen men with variable drinking histories were characterized on their ethanol-induced cardiac response, a marker previously proposed to index dopamine system reactivity and vulnerability to alcohol abuse. During separate sessions participants were administered (i) a nutritionally balanced (BAL) amino acid (AA) mixture, (ii) a mixture lacking the dopamine precursors, phenylalanine and tyrosine, and (iii) APTD followed by the dopamine precursor, L-DOPA. Five hours after AA administration, participants could earn units of alcohol using a progressive ratio breakpoint task. RESULTS: Alcohol self-administration was reduced in the APTD and APTD+L-DOPA conditions relative to the BAL condition. In both cases the changes were predicted by ethanol-induced cardiac change. CONCLUSIONS: The motivation to drink is likely regulated by more than one neurobiological mechanism. Individual differences in cardiac responsivity to ethanol might provide a peripheral marker of responsiveness to pharmacological manipulations of dopamine.
Assuntos
Consumo de Bebidas Alcoólicas/metabolismo , Consumo de Bebidas Alcoólicas/psicologia , Dopamina/metabolismo , Etanol/administração & dosagem , Individualidade , Adulto , Aminoácidos/administração & dosagem , Análise de Variância , Dopaminérgicos/administração & dosagem , Método Duplo-Cego , Frequência Cardíaca/efeitos dos fármacos , Humanos , Levodopa/administração & dosagem , Masculino , Fenilalanina/deficiência , Autoadministração , Tirosina/deficiênciaRESUMO
BACKGROUND: Pharmacological evidence support that enhancement of serotonin (5-HT) neurotransmission is critical for treatment efficacy in obsessive-compulsive disorder (OCD). Surprisingly, acute tryptophan depletion (ATD), a procedure known to reduce 5-HT neurotransmission, carried out in remitted OCD patients on selective serotonin reuptake inhibitors (SSRIs) failed to worsen obsessive-compulsive (OC) symptoms. We hypothesized that the putative symptom exacerbation resulting from ATD would only be observed during symptom provocation but not at rest. METHODS: Double-blind placebo-controlled ATD study conducted in 16 OCD patients with stable improvement under either SSRI (n = 8) or specialized cognitive behavior therapy alone (n = 8), coupled with gradual symptom provocation, performed 5 hours after drink ingestion. RESULTS: Acute tryptophan depletion markedly reduced total and free plasma tryptophan levels but did not significantly increase obsessions or compulsions at rest or following symptom provocation. However, subjective distress in response to triggering situations was significantly higher during ATD; significant mood lowering was also present during ATD. CONCLUSIONS: These results are consistent with the view that relapses in OC core symptoms in remitted OCD patients may not depend solely on short-term changes in presynaptic 5-HT availability. In contrast to its apparent lack of effect on core OC symptoms, ATD affected the patient's mood and distress level resulting from provocation.
Assuntos
Terapia Cognitivo-Comportamental/métodos , Transtorno Obsessivo-Compulsivo/terapia , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Triptofano/deficiência , Adulto , Análise de Variância , Método Duplo-Cego , Feminino , Humanos , Masculino , Escalas de Graduação Psiquiátrica , Prevenção Secundária , Resultado do Tratamento , Triptofano/metabolismoRESUMO
Reduced brain serotonin (5-hydroxytryptamine: 5-HT) transporter activity has been associated with susceptibility to various forms of psychopathology, including bulimia nervosa (BN) and related syndromes characterized by appetitive or behavioural dysregulation. We applied density (Bmax) of platelet [3H-]paroxetine binding as a proxy for central 5-HT reuptake activity in two groups of women (33 with BN-spectrum disorders and 19 with no apparent eating or psychiatric disorders), most of these individuals' mothers (31 and 18, respectively), and a small sampling of their sisters (seven and eight, respectively). Hierarchical linear modeling techniques were used to account for nesting of individuals within families and diagnostic groupings. Bulimic probands, their mothers, and their sisters all displayed significantly lower density (Bmax) of platelet-paroxetine binding than did 'control' probands, mothers, or sisters-even when relatives showing apparent eating or psychiatric disturbances were excluded. In addition, in bulimic probands and mothers, significant within-family correlations were obtained on Bmax. These findings imply a heritable trait (or endophenotype), linked to 5-HT activity, and carried by BN sufferers and their first-degree relatives (even when asymptomatic). We propose that, under conducive circumstances, such a trait may increase risk of binge-eating behavior, or associated symptoms of affective or behavioral dysregulation.
Assuntos
Plaquetas/metabolismo , Bulimia Nervosa/genética , Bulimia Nervosa/metabolismo , Paroxetina/metabolismo , Adolescente , Adulto , Bulimia Nervosa/psicologia , Feminino , Humanos , Pessoa de Meia-Idade , Linhagem , Ligação Proteica/fisiologia , Serotonina/metabolismo , Trítio/metabolismoRESUMO
RATIONALE: Nicotine increases dopamine (DA) release but its role in nicotine dependence remains unclear. OBJECTIVE: To assess the role of DA in nicotine craving and self-administration using acute phenylalanine/tyrosine depletion (APTD). METHODS: Fifteen nicotine-dependent men ingested, a minimum of 3days apart, a nutritionally balanced amino acid (AA) mixture (BAL), a mixture deficient in the catecholamine precursors, phenylalanine and tyrosine, and APTD followed by the immediate DA precursor, L-DOPA. Beginning 3h after ingestion of the AA mixture, subjects smoked 4 cigarettes. Craving, mood, and other aspects of subjective state were assessed with self-report scales. Smoking puff topography was measured with a computerized flowmeter. RESULTS: APTD did not change smoking puff topography, cigarette craving, or subjective effects of smoking. CONCLUSIONS: The findings suggest that in nicotine-dependent smokers craving for cigarettes, subjective effects of nicotine, and the self-administration of freely available cigarettes are largely unrelated to acute changes in DA neurotransmission.